Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cells

Journal of Cell Science

Volumn 127, Issue 6, 2014, Pages 1169-1178

  Chamorro Jorganes, Aránzazu ^a,b   Araldi, Elisa ^a,b   Rotllan, Noemi ^a,b   Cirera Salinas, Daniel ^c   Suárez, Yajaira ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

Endothelial cell; FGF2; Glypican 1; microRNA; MiR 149*Angiogenesis

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLYPICAN 1; MESSENGER RNA; MICRORNA; MICRORNA 149; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLASMINOGEN ACTIVATOR INHIBITOR 2; UNCLASSIFIED DRUG; FGFR1 PROTEIN, HUMAN; GLYPICAN; MIRN149 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANGIOGENESIS; ARTICLE; AUTOREGULATION; BINDING SITE; BRAIN; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; GENE CONTROL; GENETIC ALGORITHM; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRON; LUNG; NORTHERN BLOTTING; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; GENE EXPRESSION; GENETICS; LEWIS CARCINOMA; MALE; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; CARCINOMA, LEWIS LUNG; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GLYPICANS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICRORNAS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84903372353     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.130518     Document Type: Article

References (59)

1. Aikawa, T., Whipple, C. A., Lopez, M. E., Gunn, J., Young, A., Lander, A. D. and Korc, M. (2008). Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells. J. Clin. Invest. 118, 89-99.
2. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
3. Betel, D., Koppal, A., Agius, P., Sander, C. and Leslie, C. (2010). Comprehensive modeling of microRNA targets predicts functional nonconserved and non-canonical sites. Genome Biol. 11, R90.
4. Betel, D., Wilson, M., Gabow, A., Marks, D. S. and Sander, C. (2008). The microRNA.org resource: targets and expression. Nucleic Acids Res. 36, D149-D53.
5. Bushati, N. and Cohen, S. M. (2007). microRNA functions. Annu. Rev. Cell Dev. Biol. 23, 175-205.
6. Caporali, A. and Emanueli, C. (2011). MicroRNA regulation in angiogenesis. Vascul. Pharmacol. 55, 79-86.
7. Carmeliet, P. (2005). Angiogenesis in life, disease andmedicine. Nature 438, 932-936.
8. Chamorro-Jorganes, A., Araldi, E., Penalva, L. O., Sandhu, D., Fernández-Hernando, C. and Suárez, Y. (2011). MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler. Thromb. Vasc. Biol. 31, 2595-2606.
9. Cross, M. J. and Claesson-Welsh, L. (2001). FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 22, 201-207.
10. Elfenbein, A., Lanahan, A., Zhou, T. X., Yamasaki, A., Tkachenko, E., Matsuda, M. and Simons, M. (2012). Syndecan 4 regulates FGFR1 signaling in endothelial cells by directing macropinocytosis. Sci. Signal. 5, ra36.
11. Ernst, J. and Kellis, M. (2010). Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat. Biotechnol. 28, 817-825.
12. Fico, A., Maina, F. and Dono, R. (2011). Fine-tuning of cell signaling by glypicans. Cell. Mol. Life Sci. 68, 923-929.
13. Filmus, J., Capurro, M. and Rast, J. (2008). Glypicans. Genome Biol. 9, 224.
14. Folkman, J. (1984). What is the role of endothelial cells in angiogenesis? Lab. Invest. 51, 601-604.
15. Gengrinovitch, S., Berman, B., David, G., Witte, L., Neufeld, G. and Ron, D. (1999). Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J. Biol. Chem. 274, 10816-10822.
16. Gerwins, P., Sköldenberg, E. and Claesson-Welsh, L. (2000). Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit. Rev. Oncol. Hematol. 34, 185-194.
17. Hon, L. S.andZhang, Z. (2007).Theroles of bindingsitearrangement and combinatorial targeting in microRNA repression of gene expression. Genome Biol. 8, R166.
18. Inui, M., Martello, G. and Piccolo, S. (2010). MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11, 252-263.
19. Iozzo, R. V. and Sanderson, R. D. (2011). Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J. Cell. Mol. Med. 15, 1013-1031.
20. Jain, R. K. (2005). Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62.
21. Jih, Y. J., Lien, W. H., Tsai, W. C., Yang, G. W., Li, C. and Wu, L. W. (2001). Distinct regulation of genes by bFGF and VEGF-A in endothelial cells. Angiogenesis 4, 313-321.
22. Jin, L., Hu, W. L., Jiang, C. C., Wang, J. X., Han, C. C., Chu, P., Zhang, L. J., Thorne, R. F., Wilmott, J., Scolyer, R. A. et al. (2011). MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc. Natl. Acad. Sci. USA 108, 15840-15845.
23. Kleeff, J., Ishiwata, T., Kumbasar, A., Friess, H., Büchler, M. W., Lander, A. D. and Korc, M. (1998). The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J. Clin. Invest. 102, 1662-1673.
24. Kleeff, J., Wildi, S., Kumbasar, A., Friess, H., Lander, A. D. and Korc, M. (1999). Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells. Pancreas 19, 281-288.
25. Li, D., Chen, P., Li, X. Y., Zhang, L. Y., Xiong, W., Zhou, M., Xiao, L., Zeng, F., Li, X. L., Wu, M. H. et al. (2011). Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. OMICS 15, 673-682.
26. Lin, R. J., Lin, Y. C. and Yu, A. L. (2010). miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Mol. Carcinog. 49, 719-727.
27. Löffler, D., Brocke-Heidrich, K., Pfeifer, G., Stocsits, C., Hackermüller, J., Kretzschmar, A. K., Burger, R., Gramatzki, M., Blumert, C., Bauer, K. et al. (2007). Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110, 1330-1333.
28. Lutter, D., Marr, C., Krumsiek, J., Lang, E. W. and Theis, F. J. (2010). Intronic microRNAs support their host genes by mediating synergistic and antagonistic regulatory effects. BMC Genomics 11, 224.
29. Matsuda, K., Maruyama, H., Guo, F., Kleeff, J., Itakura, J., Matsumoto, Y., Lander, A. D. and Korc, M. (2001). Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res. 61, 5562-5569.
30. Megraw, M., Sethupathy, P., Gumireddy, K., Jensen, S. T., Huang, Q. H. and Hatzigeorgiou, A. G. (2010). Isoform specific gene auto-regulation via miRNAs: a case study on miR-128b and ARPP-21. Theor. Chem. Acc. 125, 593-598.
31. Mi, H., Dong, Q., Muruganujan, A., Gaudet, P., Lewis, S. and Thomas, P. D. (2010). PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res. 38, D204-D210.
32. Monteys, A. M., Spengler, R. M., Wan, J., Tecedor, L., Lennox, K. A., Xing, Y. and Davidson, B. L. (2010). Structure and activity of putative intronic miRNA promoters. RNA 16, 495-505.
33. Nikolic, I., Plate, K. H. and Schmidt, M. H. (2010). EGFL7 meets miRNA-126: an angiogenesis alliance. J. Angiogenes Res. 2, 9.
34. Okamura, K., Phillips, M. D., Tyler, D. M., Duan, H., Chou, Y. T. and Lai, E. C. (2008). The regulatory activity of microRNA* species has substantial influence on microRNA and 39 UTR evolution. Nat. Struct. Mol. Biol. 15, 354-363.
35. Olsson, A. K., Dimberg, A., Kreuger, J. and Claesson-Welsh, L. (2006). VEGF receptor signalling-in control of vascular function. Nat. Rev.Mol.Cell Biol. 7, 359-371.
36. Øster, B., Linnet, L., Christensen, L. L., Thorsen, K., Ongen, H., Dermitzakis, E. T., Sandoval, J., Moran, S., Esteller, M., Hansen, T. F. et al. (2013). Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer. Int. J. Cancer 132, 2303-2315.
37. Presta, M., Dell'Era, P., Mitola, S., Moroni, E., Ronca, R. and Rusnati, M. (2005). Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 16, 159-178.
38. Qiao, D., Meyer, K., Mundhenke, C., Drew, S. A. and Friedl, A. (2003). Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells. Specific role for glypican-1 in glioma angiogenesis. J. Biol. Chem. 278, 16045-16053.
39. Qiao, D., Yang, X., Meyer, K. and Friedl, A. (2008). Glypican-1 regulates anaphase promoting complex/cyclosome substrates and cell cycle progression in endothelial cells. Mol. Biol. Cell 19, 2789-2801.
40. Qiao, D., Meyer, K. and Friedl, A. (2012). Glypican-1 stimulates Skp2 autoinduction loop and G1/S transition in endothelial cells. J. Biol. Chem. 287, 5898-5909.
41. Rayner, K. J., Suárez, Y., Dávalos, A., Parathath, S., Fitzgerald, M. L., Tamehiro, N., Fisher, E. A., Moore, K. J. and Fernández-Hernando, C. (2010). MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570-1573.
42. Reynolds, L. P. and Redmer, D. A. (2001). Angiogenesis in the placenta. Biol. Reprod. 64, 1033-1040.
43. Ro, S., Park, C., Young, D., Sanders, K. M. and Yan, W. (2007). Tissuedependent paired expression of miRNAs. Nucleic Acids Res. 35, 5944-5953.
44. Sasisekharan, R., Shriver,Z., Venkataraman, G. and Narayanasami, U. (2002).Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer 2, 521-528.
45. Su, G., Meyer, K., Nandini, C. D., Qiao, D., Salamat, S. and Friedl, A. (2006). Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells. Am. J. Pathol. 168, 2014-2026.
46. Suárez, Y. and Sessa, W. C. (2009). MicroRNAs as novel regulators of angiogenesis. Circ. Res. 104, 442-454.
47. Suárez, Y., Fernández-Hernando, C., Pober, J. S. and Sessa, W. C. (2007). Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ. Res. 100, 1164-1173.
48. Suárez, Y., Fernández-Hernando, C., Yu, J., Gerber, S. A., Harrison, K. D., Pober, J. S., Iruela-Arispe, M. L., Merkenschlager, M. and Sessa, W. C. (2008). Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Natl. Acad. Sci. USA 105, 14082-14087.
49. Suárez, Y., Wang, C., Manes, T. D. and Pober, J. S. (2010). Cutting edge: TNFinduced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J. Immunol. 184, 21-25.
50. Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S. and Miyazono, K. (2009). Modulation of microRNA processing by p53. Nature 460, 529-533.
51. Thum, T. (2012). MicroRNA therapeutics in cardiovascular medicine. EMBO Mol. Med. 4, 3-14.
52. Urbich, C., Kuehbacher, A. and Dimmeler, S. (2008). Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. 79, 581-588.
53. van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J. and Olson, E. N. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575-579.
54. Wang, S. and Olson, E. N. (2009). AngiomiRs - key regulators of angiogenesis. Curr. Opin. Genet. Dev. 19, 205-211.
55. Wang, Y., Zheng, X., Zhang, Z., Zhou, J., Zhao, G., Yang, J., Xia, L., Wang, R., Cai, X., Hu, H. et al. (2012).MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer. PLoS ONE 7, e41693.
56. Wang, F., Ma, Y. L., Zhang, P., Shen, T. Y., Shi, C. Z., Yang, Y. Z., Moyer, M. P., Zhang, H. Z., Chen, H. Q., Liang, Y. et al. (2013). SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. J. Pathol. 229, 12-24.
57. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J. and Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248.
58. Yang, J. S., Phillips, M. D., Betel, D., Mu, P., Ventura, A., Siepel, A. C., Chen, K. C. and Lai, E. C. (2011). Widespread regulatory activity of vertebrate microRNA* species. RNA 17, 312-326.
59. Zhang, Z., Coomans, C. and David, G. (2001). Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model. J. Biol. Chem. 276, 41921-41929.